Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending November 26, 2017
No Need to Alter TKI Treatment in These Patients, Am J Hematol; ePub 2017 Oct 13; Alhuraiji, et al
Insurance Subsidy Impact on New TKI Users Assessed, Cancer; ePub 2017 Oct 4; Shen, Zhao, Liu, et al
Ruxolitinib in Patients Who Can’t Take Hydroxyurea, Blood; 2017 Oct 12; Verstovsek, Passamonti, et al
Socioeconomic Status Impact on Chronic GVHD, Biol Blood Marrow Transplant; ePub 2017 Oct 12; Hamilton, et al
Impact of Precision-Dosing Strategy with IVIG, Pharmacotherapy; ePub 2017 Oct 13; Stump, et al
Must reads for theWeek ending November 19, 2017
Azacitidine in Lower-Risk MDS Shows Promise, Oncologist; ePub 2017 Nov 8; Komrokji, et al
Clostridium Difficile Infection in People with MDS, World J Clin Oncol; 2017 Oct 10; Shaht, et al
Survival in Azacitidine-Treated Patients Assessed, Leuk Res; 2017 Oct 27; Sébert, Komrokji et al
Use This to Evaluate MRD Prior to Allo-SCT, Leuk Res; 2017 Dec; Candoni, De Marchi, et al
Detecting Minimal Residual Disease in AML, Curr Hematol Malig Rep; ePub 2017 Nov 2; Zhou, et al
Must reads for theWeek ending November 12, 2017
Long-Term Survival with Ruxolitinib Evaluated, J Hematol Oncol; 2017 Sep 29; Verstovsek, et al
Ruxolitininb Compared with Momelotinib for MF, J Clin Oncol; ePub 2017 Sep 20; Mesa, et al
Hematologic Malignancies of the Breast Studied, South Med J; 2017 Oct; Alsadi, Lin, Alnajar, et al
Autoimmune Myelofibrosis and Cytopenia Development, Acta Haematol; 2017 Sep 2; Piatek, et al
Using MPN Patient Reported Outcomes in Practice, Curr Hematol Malig Rep; ePub 2017 Sep 23; Geyer, et al
Must reads for theWeek ending November 5, 2017
Azacitidine Alone Offers Superior 1-Year Survival, Haematologica; ePub 2017 Oct 26; Medeiros, et al
Low-Dose HMAs for Lower-Risk MDS/MPNs Evaluated, Blood; 2017 Sept 28; Jabbour, Short, et al
Prognostic Impact of Therapy-Related CMML, Am J Hematol; ePub 2017 Oct 11; Patnaik, et al
Molecular Predictive and Prognostic Factors in AML, Leuk Lymphoma; ePub 2017 Nov 2; McCurdy, et al
A More Personalized Approach to AML, Clin Lymphoma Myeloma Leuk; ePub 2017 Oct 19; Sweet, et al
Must reads for theWeek ending October 29, 2017
CAR-T Cell Therapy for Certain Lymphomas Approved, FDA news release; 2017 Oct 18
Liver Dysfunction in Chronic Lymphocytic Leukemia, Am J Hematol; ePub 2017 Oct 19; Hampel, et al
This Predicts Poor Prognosis in Light Chain AL, Am J Hematol; ePub 2017 Oct 20; Tandon, et al
This Improves Survival After HLA-Haplo Transplant, Biol Blood Marrow Transplant; ePub 2017 Oct 18; McCurdy, et al
Timing of G-CSF Initiation After Auto PBSCT, Biol Blood Marrow Transplant; ePub 2017 Oct 20; Singh, et al
